论文部分内容阅读
We recently showed that chronic treatment with the target-of-rapamycin (TOR) inhibitor rapamycin, a drug that extends lifespan and delays aging in mice, halted and even reversed Alzheimer s (AD)-like memory deficits and reduced Aβ accumulation in brains of hAPP(J20) mice modeling the disease.